Increasing antimicrobial resistance in bacterial pathogens has prompted a renewed interest in alternative approaches, such as bacteriophages (viruses that infect bacteria). However, phage therapy, as traditionally envisioned, suffers from several technical as well as safety challenges. We are developing a platform for controlled phage therapy using engineered filamentous phages coupled with plasmonic nanorods. Studies in our group have validated the safety and efficacy of this approach in vitro and in vivo.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.